HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells

Nature Communications

Volumn 5, Issue , 2014, Pages

  Tabet, Fatiha ^a,b,c   Vickers, Kasey C ^d,e   Cuesta Torres, Luisa F ^a,b   Wiese, Carrie B ^e   Shoucri, Bassem M ^d   Lambert, Gilles ^f   Catherinet, Claire ^b   Prado Lourenco, Leonel ^a   Levin, Michael G ^d   Thacker, Seth ^d   Sethupathy, Praveen ^g   Barter, Philip J ^a,b,c   Remaley, Alan T ^d   Rye, Kerry Anne ^a,b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b HEART RESEARCH INSTITUTE   (Australia)

^c University of Sydney   (Australia)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITÉ DE NANTES   (France)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER G1; CELL ADHESION MOLECULE; CXCL1 CHEMOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HIGH DENSITY LIPOPROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MICRORNA 223; RIBONUCLEASE A; RNA INDUCED SILENCING COMPLEX; RNA PRECURSOR; SMALL INTERFERING RNA; VASCULAR CELL ADHESION MOLECULE 1; ZINC FINGER PROTEIN; MICRORNA; MIRN223 MICRORNA, HUMAN;

CELL ORGANELLE; GENE EXPRESSION; MOLECULAR ANALYSIS; PROTEIN; RODENT;

3' UNTRANSLATED REGION; ADULT; ANTIGEN FUNCTION; ARTICLE; CELL CULTURE; ENDOTHELIUM CELL; FAST PROTEIN LIQUID CHROMATOGRAPHY; FEMALE; FLOW CYTOMETRY; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; HUMAN; LUCIFERASE ASSAY; MALE; NORMAL HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CORONARY BLOOD VESSEL; CYTOLOGY; GENE EXPRESSION REGULATION; METABOLISM; UMBILICAL VEIN ENDOTHELIAL CELL;

ADULT; ANIMALS; CORONARY VESSELS; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEALTHY VOLUNTEERS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LIPOPROTEINS, HDL; MALE; MICE, INBRED C57BL; MICRORNAS;

EID: 84896894879     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4292     Document Type: Article

References (68)

1. Maron, D. J. The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease. Am. J. Cardiol. 86, 11L-14L (2000).
2. Barter, P. et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. New Engl. J. Med. 357, 1301-1310 (2007). (Pubitemid 47481452)
3. Di Angelantonio, E. et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302, 1993-2000 (2009).
4. Sharrett, A. R. et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 104, 1108-1113 (2001). (Pubitemid 32830392)
5. Feig, J. E. et al. HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proc. Natl Acad. Sci. USA 108, 7166-7171 (2011).
6. Nicholls, S. J. et al. Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation 111, 1543-1550 (2005). (Pubitemid 40470651)
7. Cockerill, G. W., Rye, K. A., Gamble, J. R., Vadas, M. A. & Barter, P. J. Highdensity lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler. Thromb. Vasc. Biol. 15, 1987-1994 (1995).
8. Sanson, M., Distel, E. & Fisher, E. A. HDL induces the expression of the M2 macrophage markers arginase 1 and Fizz-1 in a STAT6-dependent process. PLoS One 8, e74676 (2013).
9. Gharavi, N. M. et al. High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory. Arterioscler. Thromb. Vasc. Biol. 27, 1346-1353 (2007). (Pubitemid 46809424)
10. Camont, L., Chapman, M. J. & Kontush, A. Biological activities of HDL subpopulations and their relevance to cardiovascular disease. Trends Mol. Med. 17, 594-603 (2011).
11. Davidson, W. S. et al. Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function. Arterioscler. Thromb. Vasc. Biol. 29, 870-876 (2009).
12. Tabet, F. & Rye, K. A. High-density lipoproteins, inflammation and oxidative stress. Clin. Sci. (Lond.) 116, 87-98 (2009).
13. Yvan-Charvet, L. et al. Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation 118, 1837-1847 (2008).
14. Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D. & Remaley, A. T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423-433 (2011).
15. Vickers, K. C. & Remaley, A. T. Lipid-based carriers of microRNAs and intercellular communication. Curr. Opin. Lipidol. 23, 91-97 (2012).
16. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
17. Mendell, J. T. & Olson, E. N. MicroRNAs in stress signaling and human disease. Cell 148, 1172-1187 (2012).
18. Ebert, M. S. & Sharp, P. A. Roles for microRNAs in conferring robustness to biological processes. Cell 149, 515-524 (2012).
19. Vickers, K. C. & Remaley, A. T. MicroRNAs in atherosclerosis and lipoprotein metabolism. Curr. Opin. Endocrinol. Diabetes Obes. 17, 150-155 (2010).
20. Fichtlscherer, S., Zeiher, A. M. & Dimmeler, S. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler. Thromb. Vasc. Biol. 31, 2383-2390 (2011).
21. Schroen, B. & Heymans, S. Small but smart-microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing. Cardiovasc. Res. 93, 605-613 (2012).
22. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
23. Boon, R. A. & Vickers, K. C. Intercellular transport of microRNAs. Arterioscler. Thromb. Vasc. Biol. 33, 186-192 (2013).
24. Zhang, Y. et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 39, 133-144 (2010).
25. Kosaka, N. et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 285, 17442-17452 (2010).
26. Vickers, K. C. & Remaley, A. T. HDL and cholesterol: life after the divorce? J. Lipid Res. 55, 4-12 (2014).
27. Laffont, B. et al. Activated platelets can deliver mRNA regulatory Ago2*microRNA complexes to endothelial cells via microparticles. Blood 122, 253-261 (2013).
28. Ismail, N. et al. Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood 121, 984-995 (2013).
29. Johnnidis, J. B. et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451, 1125-1129 (2008). (Pubitemid 351317447)
30. Cheung, M. C. & Albers, J. J. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. J. Biol. Chem. 259, 12201-12209 (1984). (Pubitemid 14019758)
31. Iademarco, M. F., McQuillan, J. J., Rosen, G. D. & Dean, D. C. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J. Biol. Chem. 267, 16323-16329 (1992).
32. Chen, C. C., Rosenbloom, C. L., Anderson, D. C. & Manning, A. M. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation. J. Immunol. 155, 3538-3545 (1995).
33. Tabet, F. et al. The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro. Arterioscler. Thromb. Vasc. Biol. 30, 246-252 (2010).
34. McGrath, K. C. et al. Role of 3beta-hydroxysteroid-delta 24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 29, 877-882 (2009).
35. Burg, J., Krump-Konvalinkova, V., Bittinger, F. & Kirkpatrick, C. J. GM-CSF expression by human lung microvascular endothelial cells: in vitro and in vivo findings. Am. J. Physiol. Lung Cell Mol. Physiol. 283, L460-L467 (2002). (Pubitemid 34804004)
36. Levitt, L. J. et al. Production of granulocyte/macrophage-colony- stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor. J. Clin. Invest. 88, 67-75 (1991).
37. Hamilton, J. A. et al. Cytokine regulation of colony-stimulating factor (CSF) production in cultured human synovial fibroblasts. II. Similarities and differences in the control of interleukin-1 induction of granulocyte-macrophage CSF and granulocyte-CSF production. Blood 79, 1413-1419 (1992).
38. Scapini, P. et al. CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. J. Immunol. 172, 5034-5040 (2004). (Pubitemid 38456430)
39. Kallies, A. et al. Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance. Nat. Immunol. 7, 466-474 (2006).
40. Diehl, P. et al. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc. Res. 93, 633-644 (2012).
41. Bernstein, B. E. et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
42. Diaz-Gonzalez, F. et al. Prevention of in vitro neutrophil-endothelial attachment through shedding of L-selectin by nonsteroidal antiinflammatory drugs. J. Clin. Invest. 95, 1756-1765 (1995).
43. Sun, X. et al. MicroRNA-181b regulates NF-kappaB-mediated vascular inflammation. J. Clin. Invest. 122, 1973-1990 (2012).
44. Kane, N. M. et al. Role of microRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells. Stem Cells 30, 643-654 (2012).
45. Sumi, M. et al. Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis. Arterioscler. Thromb. Vasc. Biol. 27, 813-818 (2007). (Pubitemid 46606711)
46. Pu, D. R. & Liu, L. HDL slowing down endothelial progenitor cells senescence: a novel anti-atherogenic property of HDL. Med. Hypotheses 70, 338-342 (2008). (Pubitemid 350297601)
47. Clay, M. A. & Barter, P. J. Formation of new HDL particles from lipid-free apolipoprotein A-I. J. Lipid Res. 37, 1722-1732 (1996). (Pubitemid 26275383)
48. Blanche, P. J., Gong, E. L., Forte, T. M. & Nichols, A. V. Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim. Biophys. Acta 665, 408-419 (1981). (Pubitemid 11011381)
49. Tang, C., Liu, Y., Kessler, P. S., Vaughan, A. M. & Oram, J. F. The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor. J. Biol. Chem. 284, 32336-32343 (2009).
50. Vaughan, A. M., Tang, C. & Oram, J. F. ABCA1 mutants reveal an interdependency between lipid export function, apoA-I binding activity, and Janus kinase 2 activation. J. Lipid Res. 50, 285-292 (2009).
51. Zhu, X. et al. Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J. Biol. Chem. 283, 22930-22941 (2008).
52. Murphy, A. J. et al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler. Thromb. Vasc. Biol. 28, 2071-2077 (2008).
53. Hutchins, A. P., Poulain, S. & Miranda-Saavedra, D. Genome-wide analysis of STAT3 binding in vivo predicts effectors of the anti-inflammatory response in macrophages. Blood 119, e110-e119 (2012).
54. Venkateswaran, A. et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc. Natl Acad. Sci. USA. 97, 12097-12102 (2000).
55. Santamarina-Fojo, S. et al. Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. Proc. Natl Acad. Sci. USA. 97, 7987-7992 (2000). (Pubitemid 30460760)
56. Schmitz, G. & Langmann, T. Transcriptional regulatory networks in lipid metabolism control ABCA1 expression. Biochim. Biophys. Acta 1735, 1-19 (2005). (Pubitemid 40814509)
57. Bursill, C. A. et al. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 30, 1773-1778 (2010).
58. Shi, L. et al. MicroRNAs-223 antagonises angiogenesis by targeting beta1 integrin and preventing growth factor signaling in endothelial cells. Circ. Res. 113, 1320-1330 (2013).
59. Brundert, M. et al. Scavenger receptor CD36 mediates uptake of high density lipoproteins in mice and by cultured cells. J. Lipid Res. 52, 745-758 (2011).
60. Adachi, H. & Tsujimoto, M. Endothelial scavenger receptors. Prog. Lipid Res. 45, 379-404 (2006).
61. Rye, K. A., Garrety, K. H. & Barter, P. J. Preparation and characterization of spheroidal, reconstituted high-density lipoproteins with apolipoprotein A-I only or with apolipoprotein A-I and A-II. Biochim. Biophys. Acta 1167, 316-325 (1993). (Pubitemid 23124026)
62. Osborne, Jr J. C. Delipidation of plasma lipoproteins. Methods Enzymol. 128, 213-222 (1986). (Pubitemid 16100893)
63. Weisweiler, P. Isolation and quantitation of apolipoproteins A-I and A-II from human high-density lipoproteins by fast-protein liquid chromatography. Clin. Chim. Acta 169, 249-254 (1987). (Pubitemid 18007049)
64. Izzo, C., Grillo, F. & Murador, E. Improved method for determination of highdensity-lipoprotein cholesterol I. Isolation of high-density lipoproteins by use of polyethylene glycol 6000. Clin. Chem. 27, 371-374 (1981). (Pubitemid 11071389)
65. Matz, C. E. & Jonas, A. Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem. 257, 4535-4540 (1982).
66. Rainwater, D. L. et al. Production of polyacrylamide gradient gels for the electrophoretic resolution of lipoproteins. J. Lipid Res. 33, 1876-1881 (1992). (Pubitemid 23006665)
67. Wetterau, J. R. & Jonas, A. Effect of dipalmitoylphosphatidylcholine vesicle curvature on the reaction with human apolipoprotein A-I. J. Biol. Chem. 257, 10961-10966 (1982). (Pubitemid 13208905)
68. Takayama, M., Itoh, S., Nagasaki, T. & Tanimizu, I. A new enzymatic method for determination of serum choline-containing phospholipids. Clin. Chim. Acta 79, 93-98 (1977). (Pubitemid 8149325)